IRIS PubliCatt

Marrocco, Ilaria

Marrocco, Ilaria  

ROMA - Dipartimento di Scienze della vita e sanità pubblica  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.022 secondi).
Data di pubblicazione Titolo Autore(i) File
1-gen-2023 L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab Marrocco, Ilaria; Giri, Suvendu; Simoni-Nieves, Arturo; Gupta, Nitin; Rudnitsky, Anna; Haga, Yuya; Romaniello, Donatella; Sekar, Arunachalam; Zerbib, Mirie; Oren, Roni; Lindzen, Moshit; Fard, Damon; Tsutsumi, Yasuo; Lauriola, Mattia; Tamagnone, Luca; Yarden, Yosef
1-gen-2023 Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators Marrocco, Ilaria; Yarden, Y.
1-gen-2022 ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity Di Risola, D.; Ricci, D.; Marrocco, Ilaria; Giamogante, F.; Grieco, M.; Francioso, A.; Vasco-Vidal, A.; Mancini, P.; Colotti, G.; Mosca, L.; Altieri, F.
1-gen-2021 An interdomain helix in IRE1α mediates the conformational change required for the sensor's activation Ricci, D.; Tutton, S.; Marrocco, Ilaria; Ying, M.; Blumenthal, D.; Eletto, D.; Vargas, J.; Boyle, S.; Fazelinia, H.; Qian, L.; Suresh, K.; Taylor, D.; Paton, J. C.; Paton, A. W.; Tang, C. -H. A.; Hu, C. -C. A.; Radhakrishnan, R.; Gidalevitz, T.; Argon, Y.
1-gen-2021 Egfr in cancer: Signaling mechanisms, drugs and acquired resistance Uribe, M. L.; Marrocco, Ilaria; Yarden, Y.
1-gen-2021 Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors Haga, Y.; Marrocco, Ilaria; Noronha, A.; Uribe, M. L.; Nataraj, N. B.; Sekar, A.; Drago-Garcia, D.; Borgoni, S.; Lindzen, M.; Giri, S.; Wiemann, S.; Tsutsumi, Y.; Yarden, Y.
1-gen-2021 Roles for growth factors and mutations in metastatic dissemination Nataraj, N. B.; Marrocco, Ilaria; Yarden, Y.
1-gen-2021 TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis Uribe, M. L.; Dahlhoff, M.; Batra, R. N.; Nataraj, N. B.; Haga, Y.; Drago-Garcia, D.; Marrocco, Ilaria; Sekar, A.; Ghosh, S.; Vaknin, I.; Lebon, S.; Kramarski, L.; Tsutsumi, Y.; Choi, I.; Rueda, O. M.; Caldas, C.; Yarden, Y.
1-gen-2021 Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models Marrocco, Ilaria; Romaniello, D.; Vaknin, I.; Drago-Garcia, D.; Oren, R.; Uribe, M. L.; Belugali Nataraj, N.; Ghosh, S.; Eilam, R.; Salame, T. -M.; Lindzen, M.; Yarden, Y.
1-gen-2020 Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment Ghosh, S.; Marrocco, Ilaria; Yarden, Y.
1-gen-2020 Targeting her3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation egfr kinase inhibitor Romaniello, D.; Marrocco, Ilaria; Nataraj, N. B.; Ferrer, I.; Drago-Garcia, D.; Vaknin, I.; Oren, R.; Lindzen, M.; Ghosh, S.; Kreitman, M.; Kittel, J. C.; Gaborit, N.; Baez, G. B.; Sanchez, B.; Eilam, R.; Pikarsky, E.; Paz-Ares, L.; Yarden, Y.
1-gen-2019 Cancer Immunotherapy: The Dawn of Antibody Cocktails Marrocco, Ilaria; Romaniello, Donatella; Yarden, Yosef
1-gen-2019 Clustering of IRE1α depends on sensing ER stress but not on its RNase activity Ricci, D.; Marrocco, Ilaria; Blumenthal, D.; Dibos, M.; Eletto, D.; Vargas, J.; Boyle, S.; Iwamoto, Y.; Chomistek, S.; Paton, J. C.; Paton, A. W.; Argon, Y.
1-gen-2019 ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma Srivastava, S.; Nataraj, N. B.; Sekar, A.; Ghosh, S.; Bornstein, C.; Drago-Garcia, D.; Roth, L.; Romaniello, D.; Marrocco, Ilaria; David, E.; Gilad, Y.; Lauriola, M.; Rotkopf, R.; Kimchi, A.; Haga, Y.; Tsutsumi, Y.; Mirabeau, O.; Surdez, D.; Zinovyev, A.; Delattre, O.; Kovar, H.; Amit, I.; Yarden, Y.
1-gen-2019 Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies Maron, R.; Schechter, B.; Nataraj, N. B.; Ghosh, S.; Romaniello, D.; Marrocco, Ilaria; Noronha, A.; Carvalho, S.; Yarden, Y.; Sela, M.
1-gen-2019 Shmt2: A Stat3 signaling new player in prostate cancer energy metabolism Marrocco, Ilaria; Altieri, F.; Rubini, E.; Paglia, G.; Chichiarelli, S.; Giamogante, F.; Macone, A.; Perugia, G.; Magliocca, F. M.; Gurtner, A.; Maras, B.; Ragno, R.; Patsilinakos, A.; Manganaro, R.; Eufemi, M.
1-gen-2018 A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways Romaniello, D.; Mazzeo, L.; Mancini, M.; Marrocco, Ilaria; Noronha, A.; Kreitman, M.; Srivastava, S.; Ghosh, S.; Lindzen, M.; Salame, T. M.; Onn, A.; Bar, J.; Yarden, Y.
1-gen-2018 An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors Mancini, M.; Gal, H.; Gaborit, N.; Mazzeo, L.; Romaniello, D.; Salame, T. M.; Lindzen, M.; Mahlknecht, G.; Enuka, Y.; Burton, D. G. A.; Roth, L.; Noronha, A.; Marrocco, Ilaria; Adreka, D.; Altstadter, R. E.; Bousquet, E.; Downward, J.; Maraver, A.; Krizhanovsky, V.; Yarden, Y.
1-gen-2018 Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat Coccurello, R.; Romano, A.; Giacovazzo, G.; Tempesta, B.; Fiore, M.; Giudetti, A. M.; Marrocco, Ilaria; Altieri, F.; Moles, A.; Gaetani, S.
1-gen-2018 Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity Giamogante, F.; Marrocco, Ilaria; Cervoni, L.; Eufemi, M.; Chichiarelli, S.; Altieri, F.